David Schneider

David Schneider

Skadden, Arps, Slate, Meagher & Flom LLP

Contact
View Bio
RSS

Latest Posts › Abbreviated New Drug Application (ANDA)

Share:

The Tax Court Offers a Mixed Bag in the Mylan Case

In Mylan, Inc. & Subsidiaries v. Commissioner, 156 T.C. No. 10 (April 27, 2021), the Tax Court held that legal expenses incurred by a manufacturer of generic pharmaceutical drugs for the preparation, assembly and transmittal...more

5/11/2021  /  Abbreviated New Drug Application (ANDA) , FDA Approval , Food and Drug Administration (FDA) , Generic Drugs , Internal Revenue Code (IRC) , Mylan Pharmaceuticals , Patent Litigation , Prescription Drugs , Tax Court
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide